Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon D Murray

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injuryAndrew I R Maas, Ewout W Steyerberg, Anthony Marmarou, et al.
Critical Care Medicine|November 4, 2009
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?Bob Roozenbeek, Andrew I R Maas, Hester F Lingsma, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT studyGillian S McHugh, Doortje C Engel, Isabella Butcher, et al.
Lancet (London, England)|February 1, 2005
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trialA David Mendelow, Barbara A Gregson, Helen M Fernandes, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT studyNino A Mushkudiani, Doortje C Engel, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT studyJackelien G M Van Beek, Nino A Mushkudiani, Ewout W Steyerberg, et al.
Lancet (London, England)|May 3, 2003
New European Directive on clinical trialsNino Stocchetti, Mark Dearden, Abbi Karimi, et al.
Journal of Neurosurgery|October 22, 2003
Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patientsChantal W P M Hukkelhoven, Ewout W Steyerberg, Anneke J J Rampen, et al.
The Lancet. Neurology|May 7, 2013
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trialsWilliam N Whiteley, Harold P Adams, Philip M W Bath, et al.
Critical Care Medicine|April 19, 2012
Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic modelsBob Roozenbeek, Hester F Lingsma, Fiona E Lecky, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 5, 2010
IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injuryAndrew I R Maas, Ewout W Steyerberg, Anthony Marmarou, et al.
Critical Care Medicine|November 4, 2009
Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment?Bob Roozenbeek, Andrew I R Maas, Hester F Lingsma, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of secondary insults in traumatic brain injury: results from the IMPACT studyGillian S McHugh, Doortje C Engel, Isabella Butcher, et al.
Lancet (London, England)|February 1, 2005
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trialA David Mendelow, Barbara A Gregson, Helen M Fernandes, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT studyNino A Mushkudiani, Doortje C Engel, Ewout W Steyerberg, et al.
Journal of Neurotrauma|March 23, 2007
Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT studyJackelien G M Van Beek, Nino A Mushkudiani, Ewout W Steyerberg, et al.
Lancet (London, England)|May 3, 2003
New European Directive on clinical trialsNino Stocchetti, Mark Dearden, Abbi Karimi, et al.
Journal of Neurosurgery|October 22, 2003
Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patientsChantal W P M Hukkelhoven, Ewout W Steyerberg, Anneke J J Rampen, et al.
The Lancet. Neurology|May 7, 2013
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trialsWilliam N Whiteley, Harold P Adams, Philip M W Bath, et al.
Critical Care Medicine|April 19, 2012
Prediction of outcome after moderate and severe traumatic brain injury: external validation of the International Mission on Prognosis and Analysis of Clinical Trials (IMPACT) and Corticoid Randomisation After Significant Head injury (CRASH) prognostic modelsBob Roozenbeek, Hester F Lingsma, Fiona E Lecky, et al.
Pageof 13